Standard Biotools Income Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	92.32M		26.50M	18.78M	25.65M	27.02M	25.12M	27.67M	25.37M	28.19M	45.54M	22.49M	22.09M	24.78M	20.22M	21.76M	19.55M	23.80M	21.15M	20.10M
Cost of Revenue (Quarter)	37.72M		1.93M	14.35M	16.43M	15.85M	12.84M	14.06M	14.21M	14.83M	21.35M	12.12M	9.96M	13.42M	9.17M	11.13M	10.07M	12.41M	9.84M	9.57M
Gross Profit (Quarter)	54.60M		24.58M	4.43M	9.22M	11.17M	12.28M	13.60M	11.15M	13.36M	24.19M	10.37M	12.13M	11.36M	11.05M	10.63M	9.48M	11.38M	11.31M	10.54M
Operating items
Research & Development (Quarter)	29.40M		8.87M	12.61M	8.49M	7.42M	6.43M	6.18M	6.37M	6.91M	15.98M	7.24M	6.94M	7.04M	5.44M	6.22M	6.36M	7.97M	2.12M	1.98M
Selling, General & Administrative (Quarter)	75.93M		30.88M	30.08M	26.34M	20.22M	21.30M	22.60M	22.29M	21.35M	46.94M	24.86M	24.47M	27.32M	29.82M	28.11M	26.59M	25.34M	18.61M	16.39M
Restructuring Costs (Quarter)				0.30M	3.41M	-1.24M	1.20M	2.27M	2.00M	1.07M	17.16M	2.78M	2.34M	15.61M	1.55M	0.27M	9.43M	13.27M	3.08M	14.75M
Other Operating Expenses (Quarter)	43.19M		14.27M		0.01M	5.87M	-0.05M		1.66M	5.41M	4.28M	5.75M	5.08M	-12.52M	1.20M	1.73M	0.04M	-10.54M		2.81M
Operating Expenses (Quarter)	148.52M		54.01M	42.99M	38.25M	32.28M	28.87M	31.05M	32.33M	34.74M	84.37M	40.63M	38.83M	37.44M	38.02M	36.33M	42.42M	36.03M	23.80M	35.92M
Operating Income (Quarter)	-56.20M		-27.50M	-38.56M	-29.03M	-21.11M	-16.59M	-17.45M	-21.17M	-21.39M	-60.18M	-30.26M	-26.70M	-26.08M	-26.97M	-25.70M	-32.94M	-24.64M	-12.50M	-25.39M
EBIT (Quarter)	-56.20M		-27.50M	-38.56M	-29.03M	-21.11M	-16.59M	-17.45M	-21.17M	-21.39M	-60.18M	-30.26M	-26.70M	-26.08M	-26.97M	-25.70M	-32.94M	-24.64M	-12.50M	-25.39M
Non-operating items
Non Operating Investment Income (Quarter)
Other Non Operating Income (Quarter)	0.53M		0.12M	-0.17M	-0.06M	-0.70M	1.13M				-2.23M	0.41M		-30.22M	0.57M			0.96M	-5.63M	-0.66M
Net income details
EBT (Quarter)	-53.42M		-76.86M	-65.15M	-30.14M	153.27M	-16.58M	-16.74M	-20.95M	13.68M	-32.03M	-25.41M	-21.80M	39.25M	-23.49M	-18.28M	-32.90M	6.14M	-14.62M	-21.43M
Tax Provisions (Quarter)	-3.60M		-0.57M	-1.60M	-0.71M	0.07M	0.26M	0.30M	0.10M	-0.45M	0.10M	0.04M	0.10M	-0.04M	-0.10M	-0.60M	-1.20M	-2.42M	0.01M	0.10M
Profit After Tax (Quarter)	-49.81M		-76.29M	-63.54M	-29.43M	-20.84M	-16.84M	-17.04M	-21.00M	34.34M	-32.16M	-45.72M	-26.94M	-27.17M	-23.37M	-33.46M	-31.68M	35.35M	127.07M	-26.76M
Income from Continuing Operations (Quarter)	-49.82M		-76.29M	-63.55M	-29.43M	153.20M	-16.84M	-17.04M	-21.05M	14.13M	-32.13M	-25.44M	-21.90M	39.28M	-23.39M	-17.68M	-31.70M	8.56M	-14.63M	-21.54M
Consolidated Net Income (Quarter)	-49.82M		-76.29M	-63.55M	-29.43M	153.20M	-16.84M	-17.04M	-21.05M	14.13M	-32.13M	-20.27M	-5.02M	-6.90M	-2.66M	-15.79M	-3.00M	5.38M	141.69M	-5.23M
Income towards Parent Company (Quarter)	-49.82M		-76.29M	-63.55M	-29.43M	153.20M	-16.84M	-17.04M	-21.05M	14.13M	-32.13M	-25.44M	-21.92M	-27.17M	-2.66M	-17.67M	-31.68M	13.90M	141.69M	-5.23M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-49.82M		-76.29M	-63.55M	-29.43M	153.20M	-16.84M	-17.04M	-21.05M	14.13M	-32.13M	-25.44M	-21.92M	13.87M	-2.66M	-17.67M	-34.69M	-2.17M	141.69M	-5.23M
Additional items
EPS (Basic) (Quarter)	-0.65		-0.99	-0.82	-0.37	1.96	-0.21	-0.22	-0.27	0.18	-0.11	-0.07	-0.06	0.04	-0.01	-0.05	-0.09	-0.01	0.37	-0.01
EPS (Diluted) (Quarter)	-0.65		-0.99	-0.82	-0.37	1.96	-0.21	-0.22	-0.27	0.18	-0.11	-0.07	-0.06	0.04	-0.01	-0.05	-0.09	-0.01	0.37	-0.01
Shares Outstanding (Quarter)	76.30M	75.79M	77.03M	77.82M	78.90M	78.31M	79.08M	78.67M	79.15M	79.16M	294.12M	372.33M	371.54M	353.25M	378.23M	380.50M	382.63M	381.62M	388.20M	390.88M
Shares Outstanding (Diluted) (Quarter)	76.30M	75.79M	77.03M	77.82M	78.90M	78.31M	79.08M	78.67M	79.15M	79.16M	294.12M	372.33M	371.54M	353.25M	378.23M	380.50M	382.63M	381.62M	388.20M	390.88M
Shares Outstanding (Entity) (Quarter)	76.48M	76.92M	77.20M	78.65M	79.25M	79.90M	80.32M	82.00M	82.53M	83.36M	294.12M	389.70M	390.84M	396.11M	397.67M	400.27M	402.19M	404.96M	408.72M	410.70M
EBITDA (Quarter)	-56.20M		-27.50M	-38.56M	-29.03M	-21.11M	-16.59M	-17.45M	-21.17M	-21.39M	-60.18M	-30.26M	-26.70M	-26.08M	-26.97M	-25.70M	-32.94M	-24.64M	-12.50M	-25.39M
Interest Expenses (Quarter)	2.75M	141.10M	1.30M	1.18M	1.07M	0.35M	0.84M	1.13M	1.78M	2.40M	50.73M	12.76M	46.02M	1.44M	3.59M	0.01M	0.01M	0.01M	4.36M	2.58M
Tax Rate (Quarter)	6.74%		0.75%	2.46%	2.37%	0.05%	-1.59%	-1.79%	-0.48%	-3.27%	-0.31%	-0.15%	-0.46%	-0.09%	0.43%	3.28%	3.65%	-39.50%	-0.08%	-0.47%

Research Tools

Datasets

Plans

Developers

Standard Biotools LAB Income Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

Standard Biotools LAB Income Statement (2010-2026)

Create an account

Sign In

Reset Password